Results 101 to 110 of about 49,586 (211)

Reply: Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis.

Journal of the American College of Cardiology, 2017
not available reply to Singh A, Geller HI, Falk RH. Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis. J Am Coll Cardiol.
Maurer, Mathew S, Mundayat, Rajiv, RAPEZZI, CLAUDIO   +2 more
openaire   +3 more sources

Echocardiographic Markers of Cardiac Response to Therapy in Patients with Light Chain Amyloidosis

Echocardiography, Volume 43, Issue 3, March 2026.
In patients with AL‐CA undergoing treatment, the incorporation of left atrial and RV strain parameters correlate with left ventricular GLS and predict cardiac response. ABSTRACT Purpose The aim of this study was to identify echocardiographic parameters which correlate with cardiac response to treatment in patients with light chain cardiac amyloidosis ...
Daniel Ng, Stephanie Wu, Huiyan Ma, Sarah Lee, Carlos Gomez Luna, James Sanchez, Michael Rosenzweig, Faizi Jamal   +7 more
wiley   +1 more source

Incidental detection of ATTR cardiac amyloidosis [PDF]

Journal of Nuclear Cardiology, 2022
Jessica A, Quaggin-Smith, Ramsey M, Wehbe, Thomas A, Holly   +2 more
openaire   +2 more sources

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Hereditary Transthyretin Amyloidosis Polyneuropathy

Journal of the Peripheral Nervous System, Volume 31, Issue 1, March 2026.
ABSTRACT Background and Aims In individuals with hereditary transthyretin amyloidosis (ATTRv) polyneuropathy, monitoring of disease progression and treatment response is crucial. The objective is to determine if serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) are reliable biomarkers of ATTRv polyneuropathy ...
Valentin Loser, Pascal Benkert, Alex Vicino, Nicolas Ghika, Pansy Lim Dubois Ferrière, Chantal Daigneault, Thierry Kuntzer, Aleksandra Maleska Maceski, Jens Kuhle, Marie Théaudin   +9 more
wiley   +1 more source

Detection of ATTR aggregates in the plasma of polyneuropathic patients with ATTR-V30M amyloidosis

Amyloid
Detection of ATTR aggregates in the plasma of polyneuropathic patients with ATTR-V30M ...
Rose, Pedretti, Lanie, Wang, Justin L, Grodin, Ahmad, Masri, Jeffery, Kelly, Lorena, Saelices   +5 more
openaire   +2 more sources

Content Validation of the ATTR Amyloidosis Patient Symptom Survey: Findings from Patient and Clinician Cognitive Debriefing Interviews

Patient Related Outcome Measures, 2020
Avery A Rizio,1 Lynne E Broderick,1 Michelle K White,1 Tiffany P Quock2 1Optum Life Sciences, Patient Insights, Johnston, RI, USA; 2Prothena Biosciences Inc, South San Francisco, CA, USACorrespondence: Avery A RizioOptum Life Sciences, Patient Insights ...
Rizio AA, Broderick LE, White MK, Quock TP   +3 more
doaj  

Characterization of heterozygous ATTR Tyr114Cys amyloidosis-specific induced pluripotent stem cells

Heliyon
Hereditary transthyretin (TTR) amyloidosis (ATTRv amyloidosis) is autosomal dominant and caused by mutation of TTR gene. Heterozygous ATTR Tyr114Cys (p.Tyr134Cys) amyloidosis is a lethal disease with a life expectancy of about 10 years after onset of the
Kenta Ouchi, Kaori Isono, Yuki Ohya, Nobuaki Shiraki, Masayoshi Tasaki, Yukihiro Inomata, Mitsuharu Ueda, Takumi Era, Shoen Kume, Yukio Ando, Hirofumi Jono   +10 more
doaj   +1 more source

Kardiale ATTR-Amyloidose

Die Innere Medizin, 2023
openaire   +2 more sources

Data Management Systems (DMS): Complex data types study. Volume 1: Appendices A-B. Volume 2: Appendices C1-C5. Volume 3: Appendices D1-D3 and E [PDF]

Two categories were chosen for study: the issue of using a preprocessor on Ada code of Application Programs which would interface with the Run-Time Object Data Base Standard Services (RODB STSV), the intent was to catch and correct any mis-registration ...
Davari, Sadegh, Leibfried, T. F., Jr., Natarajan, Swami, Zhao, Wei   +3 more
core   +1 more source

Best Practices in Nuclear Imaging for the Diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in KSA: The Eagle Eyes of Local Experts

Diagnostics
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a complex and serious form of heart failure caused by the accumulation of transthyretin amyloid protein in the heart muscle. Variable symptoms of ATTR-CM can lead to a delayed diagnosis.
Abdullah Alqarni, Ahmed Aljizeeri, Aquib Mohammadidrees Bakhsh, Hossam Ahmed Maher El-Zeftawy, Hussein R. Farghaly, Mukhtar Ahmed M. Alqadhi, Mushref Algarni, Zain Mohammed Asiri, Ahmed Osman, Haya Haddadin, Islam Alayary, Mouaz H. Al-Mallah   +11 more
doaj   +1 more source